Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur Arch Otorhinolaryngol ; 273(12): 4431-4436, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27207139

RESUMEN

Medial sural artery perforator (MSAP) flap is a relatively new flap which is a modification of medial gastrocnemius myocutaneous flap. Both radial forearm flap and MSAP has common benefits, such as thinness, long pedicle and pliability; however, MSAP has lower donor site morbidity when compared with radial forearm flap. Because of this reason, the MSAP flap has gained popularity during the last decade. The objective of this study was to determine clinical application results of this flap in reconstruction of post-oncologic defects in the head and neck region. 11 patients operated for head and neck post oncologic defects and reconstructed with MSAP between June 2014 and Dec 2015 were included in the study. Age, gender, histopathology, area of reconstruction, flap size, number of perforators were reviewed. Postoperatively recipient and donor site complications, hospital stay and additional surgical procedures were also analyzed. We had seven uncomplicated cases; one total flap failure due to arterial problem, in three cases due fistula formation and local wound healing problems additional surgeries were performed. All venous anastomosis were performed with 9/0 sutures, nine arterial anastomosis were performed with 9/0 and two arterial anastomosis were performed with 10/0 nylon sutures. Medial sural artery perforator flap is a good alternative in head and neck reconstruction, with the advantages of thin and pliable skin, a reliable vascular pedicle, straightforward intramuscular dissection. But there are certain drawbacks like tedious pedicle and perforator dissection, small arterial pedicle size which complicates anastomosis and obscurities of anatomy. Surgical team must always be ready for a difficult micro anastomosis and an alternative flap choice must be prepared and counseled with the patient in case of inadequate perforators.


Asunto(s)
Procedimientos Quirúrgicos Dermatologicos/métodos , Neoplasias de Cabeza y Cuello/cirugía , Colgajo Perforante/irrigación sanguínea , Adulto , Anciano , Anciano de 80 o más Años , Anastomosis Quirúrgica , Procedimientos Quirúrgicos Dermatologicos/efectos adversos , Femenino , Neoplasias de Cabeza y Cuello/patología , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Resultado del Tratamiento
2.
Ann Plast Surg ; 75(3): 272-4, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-25536197

RESUMEN

OBJECTIVES: This study aims to analyze the efficiency of EMLA cream and ethyl chloride spray application for pain alleviation before botulinum toxin injection. METHODS: Forty-five patients were divided into 3 treatment groups. Skin cooling with ethyl chloride spray (in group 1), topical anesthetic cream (EMLA) (in group 2), was used on the forehead area on one side previous to injection; the opposite side served as the control. In the third group (n = 15), cold was applied using ethyl chloride spray to one side, and to the other side topical anesthetic cream (EMLA) was applied. A visual analog scale was used for pain intensity. RESULTS: In the first group, the average pain score was 3.20 ± 1.20 on the side where ethyl chloride spray was applied and 7.26 ± 1.94 on the control side (P < 0.05). It was 4.20 ± 1.37 on the side receiving EMLA and 7.66 ± 1.54 (P < 0.05) on the control side in the second group. In the third group, the average score was 6.80 ± 1.37 for the EMLA side and 2.93 ± 1.03 for the ethyl chloride sprayed side (P < 0.05). CONCLUSIONS: Skin cooling with ethyl chloride spray significantly decreases the pain associated during forehead botulinum toxin injections.


Asunto(s)
Inhibidores de la Liberación de Acetilcolina/efectos adversos , Anestésicos Locales/uso terapéutico , Toxinas Botulínicas Tipo A/efectos adversos , Técnicas Cosméticas/efectos adversos , Cloruro de Etilo/uso terapéutico , Lidocaína/uso terapéutico , Dolor/tratamiento farmacológico , Prilocaína/uso terapéutico , Inhibidores de la Liberación de Acetilcolina/administración & dosificación , Adulto , Aerosoles , Toxinas Botulínicas Tipo A/administración & dosificación , Estudios Cruzados , Femenino , Frente , Humanos , Inyecciones Subcutáneas , Combinación Lidocaína y Prilocaína , Persona de Mediana Edad , Dolor/inducido químicamente , Dolor/diagnóstico , Dimensión del Dolor , Estudios Prospectivos , Crema para la Piel , Resultado del Tratamiento
3.
Ophthalmic Plast Reconstr Surg ; 31(3): e57-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24481510

RESUMEN

Congenital midline nasal masses are rare anomalies that occur in about 1 in 20,000 to 40,000 live births. Nasal gliomas are thought to be collections of heterotopic tissue of neurogenic origin, which have lost their intracranial connection. It rarely cause ocular distortion and deformity in the medial orbital wall. We describe here a case of a 12-month-old baby girl diagnosed as extranasal glioma at the lateral nasal wall and medial orbital wall presenting with strabismus and subsequently treated in our service and perform a literature review.


Asunto(s)
Glioma/diagnóstico , Neoplasias Nasales/diagnóstico , Estrabismo/diagnóstico , Biopsia , Femenino , Glioma/congénito , Glioma/cirugía , Humanos , Lactante , Imagen por Resonancia Magnética , Neoplasias Nasales/congénito , Neoplasias Nasales/cirugía
4.
J Wound Ostomy Continence Nurs ; 40(6): 641-3, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24202229

RESUMEN

BACKGROUND: Pilonidal sinus is frequently managed with surgical incision. If the wound is left open to heal by secondary intention, negative pressure wound therapy (NPWT) is often used to promote healing. CASE: We describe the case of a 60-year-old patient referred after excision of a pilonidal sinus, which was managed postoperatively with NPWT. Unfortunately, the patient developed squamous cell carcinoma, which was undetected postoperatively, as the dressing was left in place for 5 days. CONCLUSION: Guidelines for the use of NPWT should be followed, with dressing intervals at 2 to 3 days. Wounds managed by NPWT should be monitored carefully for malignancy at the time of dressing changes.


Asunto(s)
Carcinoma de Células Escamosas/etiología , Terapia de Presión Negativa para Heridas/efectos adversos , Seno Pilonidal/cirugía , Complicaciones Posoperatorias , Neoplasias de los Tejidos Blandos/etiología , Humanos , Persona de Mediana Edad , Región Sacrococcígea
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...